What brought you to Ensorcell?
This was a move based on people and purpose. The management approach and the company’s goals resonate with me, and I loved the idea of being with a growing company that is doing something different.
In my Pall days, I worked with Jeff Goldman and got to see what a great leader he is. And now we get to work as a team to develop the foundation of this company; it is fulfilling to help to shape the future of what we sell and how we sell. And it helps that a lot of my background is in the lab, meaning I have practically used many life science tools. As I have transitioned into commercial roles, this has been the biggest advantage for working with customers because I understand their needs and their options.
At Ensorcell we are working to develop superior life science tools than what is currently on the market, while making them more accessible. It is just not an opportunity you get to have very often (if ever), and I am excited to be here.
How has life science tool demand evolved over time?
We have seen the market completely shift in the last six years alone. COVID caused a dramatic increase in demand for life science tools, which leveled out after the pandemic, creating a real drop in the market. The last three years have been a tough time with funding and capacity challenges abounding. As we come to the close of 2026, we are seeing the market improving, but companies are still sensitive with their capital budgets.
I would honestly say current demand is more cost sensitive than I have ever seen before. And this is what makes being part of Ensorcell such a delight, because we are working to make equipment that is safer and easier to use, while being lower cost to acquire and maintain. Because we manufacture our products in the US, it also means customers get products and without tariffs.
What differentiates Ensorcell from competitors?
The things I just mentioned before: design, affordability, access, locations, but also knowledge. The full Ensorcell leadership team comes from our industry and has a great understanding of the challenges pharmaceutical and biotech companies face. Our products are made in America with the intention of helping customers to improve drug development and production without increasing costs for the developers.
The Versaweld™ sterile tube welder is an excellent example of this ethos. It is lower cost than most welders on the market, does not use blades (which removes safety issues for the operators), is portable and uses battery power to allow operators to create welds at the point of need and not just where an electrical plug is in their room. It can also weld multiple tube sizes and materials with no changeover; just the click of a wheel.
How does the unique structure of Ensorcell impact the customer?
We have the speed and focus of a startup company, with the stability and backing of Rebuild Manufacturing (RBM) network. That format allows us the best of both worlds: the ability to focus on developing the next generation of products without the stressor of investors or funding and access to deep engineering expertise and resources. This structure is also what allows us to manufacture in America, affording our customers great savings on shipping and tariffs.
What is your favorite thing about working in the life sciences sector?
I have worked in the life science sector my entire career and I love how my job is connected to impacting and improving patient lives, and how the progress in medicine is constantly evolving.
Today we can cure diseases that we did not have 10 years ago, and I have been here to see that happen and worked on projects that impacted those outcomes. I am excited to continue to watch the life science sector industry grow and mature and honored to play a part in the progress.